首页> 外文期刊>European Heart Journal: The Journal of the European Society of Cardiology >Efficacy and safety of ticagrelor for long-term secondary prevention of atherothrombotic events in relation to renal function: insights from the PEGASUS-TIMI 54 trial
【24h】

Efficacy and safety of ticagrelor for long-term secondary prevention of atherothrombotic events in relation to renal function: insights from the PEGASUS-TIMI 54 trial

机译:替格瑞洛对肾功能相关性动脉粥样硬化栓塞事件的长期二级预防的有效性和安全性:PEGASUS-TIMI 54试验的见解

获取原文
获取原文并翻译 | 示例
           

摘要

Aims We evaluated the relationship of renal function and ischaemic and bleeding risk as well as the efficacy and safety of ticagrelor in stable patients with prior myocardial infarction (MI).
机译:目的我们评估了稳定的既往有心肌梗死(MI)的患者的肾功能与缺血性和出血风险的关系以及替加格雷的疗效和安全性。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号